Format

Send to

Choose Destination
Skin Appendage Disord. 2018 Aug;4(3):136-140. doi: 10.1159/000480023. Epub 2017 Oct 11.

Antibiofilm Treatment for Onychomycosis and Chronic Fungal Infections.

Author information

1
Department of Medicine, University of Toronto School of Medicine, Toronto, ON, Canada.
2
Mediprobe Research Inc., London, ON, Canada.
3
Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.

Abstract

Onychomycosis is a difficult-to-treat chronic fungal infection of the nail. The chronic nature of onychomycosis, with relevance to current treatment practices, could be attributed to host anergy, development of increased virulence in causal agents (multidrug resistance efflux pump), and biofilms. Biofilms must be disrupted prior to antifungal treatment suggesting the necessity of combination treatment. Once the biofilm has been disrupted, further techniques in addition to antifungal usage are suggested to ensure a positive prognosis including use of antimicrobial photodynamic therapy or low-frequency surface acoustic waves. Overall, with continued success in developing antibiofilm treatment for bacterial and yeast pathogens, therapy can be more quickly expanded to dermatophytes. With a rise in predisposing factors, it is important to preemptively address treatment for this disease with continued investigation into antibiofilm therapy including optimal treatment combinations and dosages targeted specifically at dermatophytes.

KEYWORDS:

Antibiofilm; Onychomycosis; Treatment

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center